亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

Method for Preventing or Treating Enterochromaffin Cell Typerplasia-related Diseases by Quercetin Administration

总结
It introduces a novel pharmacological use of Quercetin, which are abundantly presented in fruit, vegetables, herbs, and foodstuffs. It is effective in treating or preventing enterochromaffin (EC) cell hyperplasia-related diseases such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and irritable pouch syndrome (IPS)
技术优势
Abundant in nature, effective and no toxicity
技术应用
Prevent or treat enterochromatffin cell hyperplasia-related diseases such as inflammatory bowel disease (IBD), irritable bowel syndrome (IBS) and irritable pouch syndrome (IPS)
详细技术说明
It provides methods and compositions for preventing or treating EC cell hyperplasia-related diseases. The compositions comprise a therapeutic effective amount of Quercetin, glycosylated Quercetin, or mixture thereof. The methods comprises administering said composition as well as preparing said composition as a pharmaceutical formulation.
附加资料
Inventor: BIAN, Zhaoxiang | QIN, Hongyan | XIAO, Haitao | CHAN, Albert Sun-Chi | XU, Hongxi | CHEN, Shilin | YANG, Dajian
Priority Number: US20130210907A1
IPC Current: A61K0031353 | A23L000130
US Class: 514456 | 549400
Assignee Applicant: Hong Kong Baptist University
Title: METHOD FOR PREVENTING OR TREATING ENTEROCHROMAFFIN CELL HYPERPLASIA-RELATED DISEASES BY QUERCETIN ADMINISTRATION
Usefulness: METHOD FOR PREVENTING OR TREATING ENTEROCHROMAFFIN CELL HYPERPLASIA-RELATED DISEASES BY QUERCETIN ADMINISTRATION
Summary: For treatment or prevention of enterochromaffin cell hyperplasia-related diseases e.g. inflammatory bowel disease, irritable bowel syndrome, irritable pouch syndrome, post-infectious inflammatory bowel disease, post-infectious irritable bowel syndrome, post-infectious irritable pouch syndrome, untreated coeliac diseases, chronic gastritis of pernicious anaemia, hypergastrinemia-related diseases and gastrointestinal disorders induced by infections which occurs in mammal (claimed).
主要类别
生物医学
细分类别
医药成分
申请日期
2013.02.14
申请号码
US 13/767,865
其他
Published
ID号码
A61/BZ/Meth/US01
国家/地区
香港

欲了解更多信息,请点击 这里
移动设备